He explained that the planning for these courses began after submitting requests for specialized training and participating in coordination meetings with the European Center for Clinical Research Training (ECCRT), along with representatives from the WHO country office, the Food and Drug Administration, the Pasteur Institute, and other vaccine manufacturers. The first workshop featured Dr. Kai Dallmeier as the international instructor.

Ghaderi emphasized that the ECCRT is committed to providing professional training in clinical research, focusing on practical knowledge that participants can apply in their daily activities. The center aims to equip clinical research professionals with the skills necessary for the rapid and efficient development of new treatments while maintaining high-quality standards.

The training topics will cover a range of subjects, including mRNA and DNA vaccines, next-generation sequencing, pharmacovigilance, post-marketing surveillance, pre-marketing strategies, updates in vaccinology, and advanced GMP/CMC practices.